Market Access The UK vs. superbugs: Combatting AMR on the homefront AMR, or antimicrobial resistance, is never far from the conversation these days.
R&D London’s life sciences scene upbeat as 2024 conference seaso... With 2024 well under way, influential conferences in London have given a barometer reading on the conditions in the European biopharma market, reports Richard Staines.
R&D Green shoots and cautious optimism: Insights from BIO-Europe... With thousands of pharma and biotech dealmakers attending last months’ BIO-Europe Spring, appetite for partnering looked alive and well.
Oncology Why is pharma going gaga for radiopharmaceuticals? The pharma industry is always on the lookout for new therapeutic angles that might prove to be a competitive advantage.
Sales & Marketing Sponsored Securing top talent in a dynamic healthcare market The pharma talent market can be a tricky thing to navigate.
News Isomorphic adds MSD to partner roster, and other deals It's been a busy dealmaking week, with Isomorphic Labs, fresh from a $5 billion financing, adding MSD to its list of research alliances.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.